- Gold advances firmly, as US-10 year T-bond yields drop ten basis points, down to 1.43%.
- Risk-off market sentiment boosted the prospects of the XAU/USD, as the COVID-19 omicron variant threatens to derail the economic growth.
- XAU/USD Technical outlook: A break above $1,807 would expose $1,815, followed by $1,834.
Gold (XAU/USD) edges high during the New York session, jumping from $1,780 daily low earlier in the day towards $1,807 at press time, amid comments of Moderna’s CEO in an interview with the Financial Times, predicted a drop in existing vaccines efficacy, spurring a flight to safe-haven assets, as portrayed by US equity futures indices falling, ahead of the Wall Street’s open.
That boosted the prospects of the yellow metal, which has strengthened on the back of falling US T-bond yields, acting as a headwind for the greenback. The US 10-year Treasury yield is plummeting ten basis points, sitting at 1.43%, while the US Dollar Index, which measures the greenback’s value against a basket of its peers, falls sharply 0.74%, breaking below the 96.00 threshold, sitting at 95.65 at press time.
It seems that market participants are focused on the coronavirus omicron developments and its impact on the global economy. The fall in US bond yields reflects investors’ postures, scaling back bets of Fed hiking rates from three to two increases, depending on the ongoing COVID-19 developments.
Therefore, gold has and will keep benefitting from the abovementioned, unless data of the omicron variant show that despite being contagious, it would not be as dangerous as another COVID-19 variant.
The US macroeconomic docket so far featured the S&P/Case-Shiller Home Price Index (MoM) for September, which rose by 19,1%, more than the 19.3% expected. Meanwhile, the Chicago Purchasing Managers Index for November increased to 61.8, lower than the 67 estimated.
XAU/USD Price Forecast: Technical outlook
Gold in the 1-hour chart is approaching resistance at the R2 daily pivot level at $1,807. The 50 and the 100-hour simple moving averages (SMA’s) were left behind around the $1,796 area, while the 200-hour SMA lies in the confluence of the R3 daily pivot at $1,815, which is also the November 26 high.
On the way up, $1,815 would be the most robust line of defense for USD bulls, which in the case to be broken, would expose the September 3 high at $1,834.
On the flip side, failure to break above the former would expose the $1,800 figure, followed by the confluence of the 50 and the 100-hour SMA’s around the $1,892-94 range.
|Today last price||1807.95|
|Today Daily Change||24.25|
|Today Daily Change %||1.36|
|Today daily open||1783.7|
|Previous Daily High||1799.45|
|Previous Daily Low||1780.18|
|Previous Weekly High||1849.14|
|Previous Weekly Low||1778.63|
|Previous Monthly High||1813.82|
|Previous Monthly Low||1746.07|
|Daily Fibonacci 38.2%||1787.54|
|Daily Fibonacci 61.8%||1792.09|
|Daily Pivot Point S1||1776.1|
|Daily Pivot Point S2||1768.51|
|Daily Pivot Point S3||1756.83|
|Daily Pivot Point R1||1795.37|
|Daily Pivot Point R2||1807.05|
|Daily Pivot Point R3||1814.64|
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.